430 results on '"Doranz, Benjamin J."'
Search Results
2. Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interface
3. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
4. Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes
5. Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes
6. Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point
7. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
8. Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
9. Breaking barriers in antibody discovery: harnessing divergent species for accessing difficult and conserved drug targets
10. Testing for Off-target Binding
11. A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants.
12. Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics
13. An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
14. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
15. Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses
16. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
17. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
18. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
19. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
20. Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles
21. Abstract 2646: Screening the membrane proteome to determine antibody specificity and de-risk CAR-T cell development
22. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein
23. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices
24. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region
25. Mxra8 is a receptor for multiple arthritogenic alphaviruses
26. Differential Utilization of CCR5 by Macrophage and T Cell Tropic Simian Immunodeficiency Virus Strains
27. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
28. Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity
29. A Small-molecule Inhibitor Directed against the Chemokine Receptor CXCR4 Prevents its Use as an HIV-1 Coreceptor
30. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice
31. HCV E2 core structures and mAbs: something is still missing
32. Abstract 317: Isolation of highly selective antibodies against claudin 18.2 for the treatment of solid tumors
33. Abstract 318: Atomic-level specificity of Claudin 6 monoclonal antibodies isolated for treating solid tumors
34. Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function
35. Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening
36. RETRACTED: Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity
37. Atomic-level functional model of dengue virus Envelope protein infectivity
38. Targeting of HIV- and SIV-Infected Cells by CD4-Chemokine Receptor Pseudotypes
39. A New Generation of Antiviral Therapeutics Designed to Prevent the Use of Chemokine Receptors for Entry by HIV-1
40. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8⁺ T cells
41. Systematic analysis of human antibody response to ebolavirus glycoprotein reveals high prevalence of neutralizing public clonotypes
42. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
43. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection
44. Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
45. Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
46. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress
47. Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope
48. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
49. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
50. Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.